ECS Botanics Holdings Past Earnings Performance
Past criteria checks 2/6
ECS Botanics Holdings has been growing earnings at an average annual rate of 47.3%, while the Pharmaceuticals industry saw earnings growing at 47.3% annually. Revenues have been growing at an average rate of 86.8% per year. ECS Botanics Holdings's return on equity is 10.6%, and it has net margins of 12.5%.
Key information
47.3%
Earnings growth rate
52.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 31.2% |
| Revenue growth rate | 86.8% |
| Return on equity | 10.6% |
| Net Margin | 12.5% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How ECS Botanics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 20 | 2 | 6 | 0 |
| 30 Sep 23 | 18 | 1 | 6 | 0 |
| 30 Jun 23 | 15 | 0 | 5 | 0 |
| 31 Dec 22 | 10 | 2 | 2 | 0 |
| 30 Sep 22 | 7 | 1 | 2 | 0 |
| 30 Jun 22 | 5 | 0 | 2 | 0 |
| 31 Mar 22 | 5 | -3 | 4 | 0 |
| 31 Dec 21 | 3 | -4 | 4 | 0 |
| 30 Sep 21 | 2 | -4 | 4 | 0 |
| 30 Jun 21 | 1 | -4 | 4 | 0 |
| 31 Mar 21 | 1 | -4 | 4 | 0 |
| 31 Dec 20 | 1 | -4 | 4 | 0 |
| 30 Sep 20 | 1 | -4 | 3 | 0 |
| 30 Jun 20 | 1 | -5 | 2 | 0 |
| 31 Dec 19 | 0 | -4 | 1 | 0 |
| 30 Sep 19 | 0 | -2 | 1 | 0 |
| 30 Jun 19 | 0 | -1 | 0 | 0 |
Quality Earnings: ECS has high quality earnings.
Growing Profit Margin: ECS's current net profit margins (12.5%) are lower than last year (22.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ECS has become profitable over the past 5 years, growing earnings by 47.3% per year.
Accelerating Growth: ECS's earnings growth over the past year (16%) is below its 5-year average (47.3% per year).
Earnings vs Industry: ECS earnings growth over the past year (16%) did not outperform the Pharmaceuticals industry 16%.
Return on Equity
High ROE: ECS's Return on Equity (10.6%) is considered low.